According to the news report, the device giant is ready to commit to an acquisition priced at “$10 million to something much more significant” in order to expand its offerings in minimally invasive surgery. The company has $221 million in cash and equivalents as of June 30.
More Articles on Orthopedic Devices:
RTI Biologics Reports $45.2M 2Q Revenue, Up 4%
ArthroCare 2Q Revenue Hits $91.7M, Up 0.5%
Globus Medical Announces Pricing of Initial Public Offering
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.